Historical record - last NADAC effective date: 5/17/2023

Product Information

TUSSIN CF MULTI-SYMPTOM COLD is a generic product labeled by Cardinal Health, priced at $0.0165 per ML under NDC 70000013301. Its NADAC has been published 281 times since Jan 3, 2018.

TUSSIN CF MULTI-SYMPTOM COLD

Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI
$0.0165per ML
OTC

Strength

20; 200; 10 mg/10mL; mg/10mL; mg/10mL

Manufacturer

Cardinal Health

NDC

70000013301

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Effective Date

5/17/2023

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

1/31/2017

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price Statistics

The NADAC for TUSSIN CF MULTI-SYMPTOM COLD has been published 281 times since Jan 3, 2018, and over the history we have for it it has risen 10.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0165 per ML
All-time high$0.0222 (Oct 14, 2020)
All-time low$0.0138 (Mar 17, 2021)
Median price$0.0173
Average price$0.0176
Largest weekly change+22.7% (Apr 21, 2021)
Weeks tracked281
Tracking sinceJan 3, 2018

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

-4.1%

All

+10.8%

Last surveyed May 17, 2023 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextromethorphan HBr, Guaifenesin, Phenylephrine HCI market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of TUSSIN CF MULTI-SYMPTOM COLD?

The current National Average Drug Acquisition Cost (NADAC) for TUSSIN CF MULTI-SYMPTOM COLD, manufactured by Cardinal Health, is $0.0165 per ML (NDC 70000013301), effective May 17, 2023.

How has the price of TUSSIN CF MULTI-SYMPTOM COLD changed over time?

Over the history we have for it, the NADAC for TUSSIN CF MULTI-SYMPTOM COLD has risen 10.8%. It has been tracked across 281 weekly CMS publications since Jan 3, 2018.

What are the highest and lowest recorded NADAC prices for TUSSIN CF MULTI-SYMPTOM COLD?

Since Jan 3, 2018, the NADAC for TUSSIN CF MULTI-SYMPTOM COLD has ranged from a low of $0.0138 (Mar 17, 2021) to a high of $0.0222 (Oct 14, 2020), with a median of $0.0173 per ML.

Are there cheaper alternatives to TUSSIN CF MULTI-SYMPTOM COLD?

No other NADAC-published product currently shares the active ingredient and strength of TUSSIN CF MULTI-SYMPTOM COLD in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TUSSIN CF MULTI-SYMPTOM COLD?

TUSSIN CF MULTI-SYMPTOM COLD (NDC 70000013301) is labeled by Cardinal Health, and CMS classifies it as a generic product.